These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20198623)

  • 1. NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells.
    Mailloux AW; Clark AM; Young MR
    Int J Cancer; 2010 Dec; 127(11):2598-611. PubMed ID: 20198623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.
    Mailloux AW; Young MR
    J Immunol; 2009 Mar; 182(5):2753-65. PubMed ID: 19234170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.
    Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Hidaka T; Aiba S
    Anticancer Res; 2017 Jul; 37(7):3461-3471. PubMed ID: 28668835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells.
    Lundqvist A; Yokoyama H; Smith A; Berg M; Childs R
    Blood; 2009 Jun; 113(24):6120-7. PubMed ID: 19202127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
    Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
    Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment.
    Layseca-Espinosa E; Korniotis S; Montandon R; Gras C; Bouillié M; Gonzalez-Amaro R; Dy M; Zavala F
    J Immunol; 2013 Sep; 191(5):2266-72. PubMed ID: 23878314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased IL-17RB expression impairs CD11b
    Teng YS; Liu YG; Chen XH; Wang TT; Cheng P; Lv YP; Kong H; Mao FY; Hao CJ; Yang SM; Chen W; Zhang JY; Peng LS; Han B; Ma Q; Han J; Zou QM; Zhuang Y
    Cell Death Dis; 2019 Jan; 10(2):79. PubMed ID: 30692510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumors induce the formation of suppressor endothelial cells in vivo.
    Mulligan JK; Young MR
    Cancer Immunol Immunother; 2010 Feb; 59(2):267-77. PubMed ID: 19669642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
    Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
    PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
    Cekic C; Day YJ; Sag D; Linden J
    Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.
    Faget J; Biota C; Bachelot T; Gobert M; Treilleux I; Goutagny N; Durand I; Léon-Goddard S; Blay JY; Caux C; Ménétrier-Caux C
    Cancer Res; 2011 Oct; 71(19):6143-52. PubMed ID: 21852386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy suppressed tumor-specific recruitment of regulator T cells via up-regulating microR-545 in Lewis lung carcinoma cells.
    Liao C; Xiao W; Zhu N; Liu Z; Yang J; Wang Y; Hong M
    Int J Clin Exp Pathol; 2015; 8(3):2535-44. PubMed ID: 26045759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
    Yin X; Yan X; Yang Q; Cao H; Liang H
    Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
    Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
    Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
    Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibody-based delivery of interleukin-12 to solid tumors boosts NK and CD8
    Puca E; Probst P; Stringhini M; Murer P; Pellegrini G; Cazzamalli S; Hutmacher C; Gouyou B; Wulhfard S; Matasci M; Villa A; Neri D
    Int J Cancer; 2020 May; 146(9):2518-2530. PubMed ID: 31374124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo.
    Ke M; Wang H; Zhang M; Tian Y; Wang Y; Li B; Yu J; Dou J; Xi T; Zhou C
    Biochem Pharmacol; 2014 May; 89(1):119-30. PubMed ID: 24630931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Li A; Barsoumian HB; Schoenhals JE; Caetano MS; Wang X; Menon H; Valdecanas DR; Niknam S; Younes AI; Cortez MA; Welsh JW
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):903-912. PubMed ID: 30905636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice.
    Salem ML; El-Naggar SA; Mobasher MA; Elgharabawy RM
    J Immunol Res; 2020; 2020():2489407. PubMed ID: 32211442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
    Li ZQ; Wang HY; Zeng QL; Yan JY; Hu YS; Li H; Yu ZJ
    Cancer Med; 2020 Jan; 9(2):711-723. PubMed ID: 31769216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.